Navigation Links
Anadys Pharmaceuticals Initiates Phase IIb Study of ANA598 in HCV Patients
Date:1/4/2011

onducting the study at sites within and outside the United States.

Naive Arm

Approximately 100 treatment-naive HCV patients are expected to receive ANA598 in combination with SOC and 33 treatment-naive HCV patients are to receive placebo plus SOC.  Treatment duration for naive patients will be response-guided; patients who achieve undetectable levels of virus at Week 8 and maintain undetectable levels of virus will be scheduled to conclude all treatment at Week 28.  For naive patients with detectable virus at Week 8 dosing with ANA598, or placebo, and SOC is planned to continue through Week 48.  The Company expects to receive Week 8 antiviral response data by the end of the second quarter of 2011, Week 12 antiviral response data in the third quarter of 2011 and Week 24 antiviral response data in the fourth quarter of 2011.

Treatment-Experienced Arm, Including Prior Null Responders

Approximately 80 patients who were partial responders during, or relapsers after, a prior course of therapy with SOC alone are expected to receive ANA598 in combination with SOC, and 33 corresponding patients are to receive placebo plus SOC.  Additionally, approximately 28 prior null responder patients are to receive ANA598 in combination with SOC.  All treatment-experienced patients who receive ANA598 are scheduled to receive triple combination therapy for 48 weeks.  For the treatment-experienced patients, the Company expects to receive Week 12 antiviral response data in the third quarter of 2011 and Week 24 antiviral response data in the fourth quarter of 2011.

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C.  The Company believes hepatitis C represents a large unmet medical need in which meaningful improvements in treatment outcomes may be attainable wit
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anadys Pharmaceuticals Reports Third Quarter 2010 Financial Results and Highlights
2. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
3. Anadys Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
4. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Anadys Pharmaceuticals to Present at the BMO Capital Markets Healthcare Conference
6. Anadys Pharmaceuticals to Report Second Quarter 2010 Financial Results
7. Anadys Retains Lazard as Strategic Advisor
8. Anadys Pharmaceuticals to Present at the ROTH OC Growth Stock Conference
9. Anadys Pharmaceuticals to Present at the Cowen and Company Healthcare Conference
10. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
11. Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... ANGELES , March 31, 2015  On ... mesothelioma will convene in Santa Monica, ... Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma ... from exposure to asbestos and commonly affects the ... is co-hosted by UCLA and the Pacific Mesothelioma ...
(Date:3/31/2015)... , March 31, 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ... developing premium quality medical marijuana products and a licensed ... Medical Purposes Regulations ( Canada ) ("MMPR"), ... from The Corporation of the District of ... the Company,s premises which now allows for commercial distribution ...
(Date:3/31/2015)... Minn. , March 31, 2015 ANI ... the launch of Propafenone Hydrochloride 150mg, 225mg and 300mg ... various arrhythmias. The overall US market for Propafenone Hydrochloride ... 2014, per IMS Health. Arthur S. ... are pleased to announce the launch of our fourth ...
Breaking Medicine Technology:Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 3Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 4T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3
... N.J., Dec. 17, 2010 Par Pharmaceutical Companies, Inc. (NYSE: ... has resigned his positions as President of Strativa Pharmaceuticals and ... interests effective January 31, 2011 .  Patrick G. LePore, ... oversight of Strativa on an interim basis. ...
... Inc. (Nasdaq: ESRX ), today announced plans ... area — the third office building and fourth facility ... (Logo: http://photos.prnewswire.com/prnh/20080827/EXPRESSSCRIPTSLOGO ) The ... that found Express Scripts generates about $1 billion in ...
Cached Medicine Technology:John A. MacPhee Resigns From Strativa Pharmaceuticals 2Express Scripts Announces Plan to Build Fourth Building at Headquarters Campus 2Express Scripts Announces Plan to Build Fourth Building at Headquarters Campus 3
(Date:3/31/2015)... (PRWEB) March 31, 2015 At Summit Breast ... all patients in a calm and caring manner. , Summit ... diagnosis and surgical treatment of breast cancer. They treat ... but from all over the world. Their doctors continue ... publications. , The seeds for Summit Breast Care were planted ...
(Date:3/31/2015)... March 31, 2015 Dr. Uzma Parvez is ... 19th, Dr. Parvez conducted Grand Grounds Presentations at St. Michael’s ... and Managing Side Effects”. The event was attended by ... She received very positive feedback from the Grand Rounds. ... that they’ve had in a while. , Ahead, Dr. ...
(Date:3/31/2015)... Beckman Coulter is sponsoring a new ... Particulate Matter in Therapeutic Protein Injections”,” an educational session that ... counting particles in liquids, with a focus on the challenges ... to attend and will be broadcast live April 8, 2015 ... test for protein-based materials, known as USP 787 , ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Former 49ers linebacker ... than during his first year of a promising NFL career. ... Sports on Earth Senior Writer Will Leitch explores the ... league. Leitch talks about the decision making process that Borland ... preservation of health over a large paycheck, and what impact, ...
(Date:3/31/2015)... 2015 BESLER Consulting today announced ... Value of an Independent Cost Report Review.” , ... critical role in the determination of Medicare reimbursement ... understanding and review, this report can assist management ... , This white paper discusses:, ...
Breaking Medicine News(10 mins):Health News:Summit Breast Care is Celebrating Four Years as "NJ Top Docs" 2Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 3Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3
... UK (September 1, 2010) Faith based schools are ... standards. But are religious values at odds with legislation ... Education Management Administration and Leadership published by SAGE shows ... state diverge, with unfortunate consequences for gay students and ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, ... fruits and vegetables and low in saturated fats can ... mildly elevated blood pressure, Johns Hopkins University researchers say. ... (Dietary Approaches to Stop Hypertension) -- was designed to lower ...
... is the leading cause of cancer deaths worldwide, and ... successful. Furthermore, the incidence of one type of lung ... better understanding of the changes in tumor cell biology ... of an abnormal mass of tissue) that have been ...
... fewer than eight hours of sleep per night have greater ... depressive and anxious symptoms, according to a study in the ... Using an average self-reported nightly sleep duration of eight to ... association between sleep durations of less than eight hours and ...
... expedite the communication of urgent findings and improve patient ... of the Journal of the American College of ... in the United States is moving toward 24/7 coverage, ... as computed tomography (CT) and magnetic resonance imaging (MRI) ...
... A new study underscores the importance for women with a family ... testing for the BRCA1 and BRCA2 genes that make them more ... Medicine oncologist. The study, which will be published in ... Association ( JAMA ), shows women with the gene live longer ...
Cached Medicine News:Health News:Keeping faith -- schools must balance ethos with equality 2Health News:'DASH Diet' Shown to Lower Heart Attack Risk Almost 20% 2Health News:'DASH Diet' Shown to Lower Heart Attack Risk Almost 20% 3Health News:Tumor budding identified as predictor for unfavorable outcome in lung cancer 2Health News:Study links shorter sleep durations with greater risks of mental distress in young adults 2Health News:Study links shorter sleep durations with greater risks of mental distress in young adults 3Health News:Staggered radiologist work shifts improve patient care, study suggests 2Health News:Preventive cancer surgeries save women's lives 2
... to detect sequences of the following ... 2 and 3; influenza virus A ... A and B. Laboratories may ... tests., *Analyte Specific Reagents. ...
... molecular labs a more advanced alternative for ... MGB technology, combined with post-PCR dissociation melt ... provide molecular labs more powerful tools for ... or genetic mutations associated with disease, as ...
... NGEN-brand ASRs* are specifically designed for ... with two-color fluorescence detection systems. The ... the detection of mutations associated with ... as well as reagents for the ...
... offers reagents for the detection of ... the G1691A mutation on the Factor ... mutation on the Prothrombin gene. Laboratories ... homebrew tests.,, *Analyte Specific ...
Medicine Products: